Disciplines
Clinical Medicine (70%); Medical-Theoretical Sciences, Pharmacy (30%)
Keywords
Serotonin,
Anorexia nervosa,
Positron Emission Tomography,
Neuroimaging,
Bulimia nervosa
Abstract
Several lines of evidence suggest that individuals with bulimia nervosa (BN) and anorexia nervosa (AN) have
persistent disturbances of brain serotonin (5-HT) neurotransmission after recovery. The 5-HT1a and 5-HT2a
receptor system is of particular interest in AN and BN because this receptor has been implicated in feeding and
mood modulation as well as response to antidepressant medication (acting on 5-HT system). This application will
apply new technologies with the potential for increased understanding of previously inaccessible brain
neurotransmitter function and its dynamic relationship with human behaviors. We will use Positron Emission
Tomography (PET) imaging with the selective radioligand (Carbonyl-11C)WAY100635 to assess regional binding
of 5HT1a receptor and the selective radioligand [18F]altanserin to assess regional binding of 5-HT2a receptor
because disturbances of these receptors could contribute to behavioral disturbances in AN and BN. Altered
functional activity of these receptors may serve to confirm that a dysfunction of 5-HT neuronal activity persists
after recovery. We hypothesize that women recovered from AN or BN have increased 5-HT1a and decreased 5-
HT2a binding compared to healthy controls. This application will therefore study women ages 18 to 45 years old
who are: 1) recovered from bulimia nervosa (recovery is defined as>1 year normal menses, no bingeing and
purging, and healthy and stable weight) (n=15); 2) recovered from bulimia-type anorexia nervosa (n=5) and 3)
healthy control women (CW) (n=10). These data may be of heuristic value in devising new treatment interventions
for this often chronic and relapsing disorders.